Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polymorphism Analysis of HLA-DRB1*04 Alleles in Patients With Type 2 Diabetic Macroangiopathy in Northeast Chinese

NCT02882945 is registered in ClinicalTrials.gov with First Affiliated Hospital of Harbin Medical University as lead sponsor.

NCT NCT02882945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02882945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polymorphism Analysis of HLA-DRB1*04 Alleles in Patients With Type 2 Diabetic Macroangiopathy in Northeast Chinese
Lead sponsor
First Affiliated Hospital of Harbin Medical University
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
September 30, 2015
Enrollment
470 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic angiopathies